EUVIMEDEUVIMED entdecken
Open Access

Small airway fibroblasts from patients with chronic obstructive pulmonary disease exhibit cellular senescence

Catherine L Wrench iD, Jonathan R Baker, Sue Monkley, Peter S Fenwick, Lynne Murray, Louise E Donnelly iD, Peter J Barnes

American Journal of Physiology-Lung Cellular and Molecular Physiology · 01.03.2024 · 326 (3) · L266-L279

DOI: 10.1152/ajplung.00419.2022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Lung Cellular and Molecular Physiology, erschienen am 01.03.2024. Verfasst von Catherine L Wrench und 6 weiteren Autor:innen. Beteiligte Einrichtung: Airway Disease Section, National Heart and Lung Institute, Imperial College, London, United Kingdom. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Asthma, Mitochondrial Diseases. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: UKRI | Biotechnology and Biological Sciences Research Council (BBSRC), Wellcome Trust (WT), AstraZeneca (AstraZeneca PLC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibroblasts and senescence are thought to play key roles in the pathogenesis of small airway disease and COPD; however, the characteristics of small airway-derived fibroblasts are not well explored. In this study we isolate and enrich the senescent small airway-derived fibroblast (SAF) population from COPD lungs and explore the pathways driving this phenotype using bulk RNA-seq.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveAsthmaMitochondrial DiseasesHumansLungCellular SenescenceFibroblasts

Stichwörter der Autor:innen

COPDfibroblastsenescencesmall airway disease

Autor:innen und Institutionen

  • Airway Disease Section, National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Bioscience COPD/IPF, Research and Early Development, Respiratory & Immunology (R&I), Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
  • Translation Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology (R&I), Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

ORCID-Profile: Catherine L Wrench, Louise E Donnelly

Förderung

  • UKRI | Biotechnology and Biological Sciences Research Council (BBSRC)
  • Wellcome Trust (WT)
  • AstraZeneca (AstraZeneca PLC)
  • Medical Research Council
  • Imperial College London (ICL)
  • National Heart and Lung Institute

Zitieren

APA

Wrench, C. L., Baker, J. R., Monkley, S., Fenwick, P. S., Murray, L., Donnelly, L. E., & Barnes, P. J. (2024). Small airway fibroblasts from patients with chronic obstructive pulmonary disease exhibit cellular senescence. American Journal of Physiology-Lung Cellular and Molecular Physiology, 326(3), L266-L279. https://doi.org/10.1152/ajplung.00419.2022

Vancouver

Wrench CL, Baker JR, Monkley S, Fenwick PS, Murray L, Donnelly LE, et al. Small airway fibroblasts from patients with chronic obstructive pulmonary disease exhibit cellular senescence. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2024;326(3):L266-L279. doi:10.1152/ajplung.00419.2022

BibTeX
@article{Wrench2024,
  author = {Wrench, Catherine L and Baker, Jonathan R and Monkley, Sue and Fenwick, Peter S and Murray, Lynne and Donnelly, Louise E and Barnes, Peter J},
  title = {Small airway fibroblasts from patients with chronic obstructive pulmonary disease exhibit cellular senescence},
  journal = {American Journal of Physiology-Lung Cellular and Molecular Physiology},
  year = {2024},
  volume = {326},
  number = {3},
  pages = {L266--L279},
  doi = {10.1152/ajplung.00419.2022}
}
Kostenlos starten →